RESHORING CASE

Ypsomed

Company details
Company name: 
Ypsomed Holding AG
Group name: 
Ypsomed Holding AG
Company country: 
Switzerland
Number of employees: 
1500
Sector: 
C - Manufacturing
Sector detail: 
C26 - Manufacture of computer, electronic and optical products
Sub-sectors: 
C26.5 - Manufacture of instruments and appliances for measuring, testing navigation; watches and clocks
Reshoring details
Reshoring announcement date: 
23/04/2018
Reshored to: 
Switzerland
Location of affected unit(s): 
Burgdorf
Reshored business function: 
Production
Reshoring governance mode: 
In house (in own facilities)
Reasons for reshoring: 
Automation of production process
Rationalization of costs
Case narrative: 

Ypsomed is a Swiss-based developer and manufacturer of devices for self administration of insulin (e.g. pens). In 2018, the company decided to reshore to Switzerland the production of insulin pens it had been outsourced and offshored in Mexico in the '80. The reshoring decision was implemented after huge investments in technology; among them, the adoption of automated production process - within the company and its suppliers - and the digitalization of selected production processes through the 5G telecommunication technology (realized in partnership with Swisscom). These technologies allowed simpler, safer, and more efficient processes, increasing company's flexibility and reducing production costs.

Sources: 

Ypsomed 05/03/2018

Swisscom 23/04/2018

20min.ch 09/09/2018

Offshoring details
Offshoring date: 
1980
Offshoring location: 
Mexico
Offshored business function: 
Production
Offshoring governance mode: 
Third party (external suppliers)
Host country geographical area: 
North America